1. Tumoral and Choroidal Vascularization
- Author
-
Chantal Humblet, Julie Lecomte, Maud Jost, Peter Carmeliet, Vincent Lambert, Jean-Marie Rakic, Khalid Bajou, Catherine Maillard, Silvia Blacher, Francis Frankenne, Marie Paule Defresne, Maria-Luz Alvarez Gonzalez, Patrick Motte, Marc Tjwa, André Gothot, Pierre Blaise, Jean-Michel Foidart, Marc Thiry, and Agnès Noël
- Subjects
Pathology ,medicine.medical_specialty ,Angiogenesis ,Biology ,Pathology and Forensic Medicine ,Neovascularization ,chemistry.chemical_compound ,Choroidal neovascularization ,medicine.anatomical_structure ,chemistry ,Plasminogen activator inhibitor-1 ,medicine ,Bone marrow ,Stem cell ,medicine.symptom ,Progenitor cell ,Plasminogen activator - Abstract
An adequate balance between serine proteases and their plasminogen activator inhibitor-1 (PAI-1) is critical for pathological angiogenesis. PAI-1 deficiency in mice is associated with impaired choroidal neovascularization (CNV) and tumoral angiogenesis. In the present work, we demonstrate unexpected differences in the contribution of bone marrow (BM)-derived cells in these two processes regulated by PAI-1. PAI-1−/− mice grafted with BM-derived from wild-type mice were able to support laser-induced CNV formation but not skin carcinoma vascularization. Engraftment of irradiated wild-type mice with PAI-1−/− BM prevented CNV formation, demonstrating the crucial role of PAI-1 delivered by BM-derived cells. In contrast, the transient infiltration of tumor transplants by local PAI-1-producing host cells rather than by BM cells was sufficient to rescue tumor growth and angiogenesis in PAI-1-deficient mice. These data identify PAI-1 as a molecular determinant of a local permissive soil for tumor angiogenesis. Altogether, the present study demonstrates that different cellular mechanisms contribute to PAI-1-regulated tumoral and CNV. PAI-1 contributes to BM-dependent choroidal vascularization and to BM-independent tumor growth and angiogenesis.
- Published
- 2007
- Full Text
- View/download PDF